New 56-week data from an interim analysis of the phase III ARCADIA long-term extension study will be presented, with nemolizumab demonstrating a ...

USA News Group – Optimism is on the rise in fight against cancer, as researchers are making progress across the field of oncology. Helping to spur on the momentum, philanthropists recently gave a ...

MDCX READ THE FULL V.MDCX RESEARCH REPORT First Patient Randomized for Medicus Pharma’s Phase 2 Clinical Study (SKNJCT-003) ...

University of California San Diego is conducting new, Phase 2/3 national epilepsy clinical research trials, called Rise, to ...

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

Besides stomach cancer, the FDA also raised a similar concern for PD-1 drugs in first-line esophageal squamous cell carcinoma ...

AI-assisted pathology will enable early, accurate diagnosis of liver disease and offer insights that predict which patients ...

Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond th ...

All in all, PR’s Strong Buy consensus rating is based on 16 reviews that include 14 Buys against just 2 Holds. With a trading price of $14.18 and an average target price of $19.43, Permian’s stock has ...

The FDA granted fast track designation to EO-3021 for the treatment of advanced or metastatic gastric and gastroesophageal ...

A short course of treatment with RNS60, as an add-on to riluzole, extended the survival of ALS patients by about six months, ...